Healthcare giants AbbVie, Abbott raise dividends consistently

AbbVie and Abbott Laboratories, both healthcare companies, are recommended as strong dividend stocks for long-term passive income. They are expected to continue rewarding shareholders with consistent dividend increases. AbbVie's revenue increased, driven by immunology medicines Skyrizi and Rinvoq, and has a strong pipeline. Abbott Laboratories, known for medical devices, also shows consistent revenue and dividend growth, particularly in diabetes care. Both companies are Dividend Kings, with long histories of increasing payouts. Their diversified operations and innovative products position them well for sustained success and continued dividend growth for investors.